Top Markets
#1 Black Phoenix Black Phoenix +355.20%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.60%
#4 Akedo Akedo +60.88%
#5 OpenEden OpenEden +54.74%
#6 Acurast Acurast +29.22%
#7 BasedHype BasedHype +27.20%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +18.96%
#10 Ether.fi Ether.fi +17.29%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rang in Aktien #40618
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aktienkurs
$1.06
Zuletzt synchronisiert: 2021-06-25
Marktkapitalisierung
$110.93K
Veränderung (1 Tag)
-5.36%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Kategorie

Healthcare
Kursverlauf für Millendo Therapeutics, Inc. (MLND)
Höchster Schlusskurs: $1.33 am 2021-06-01

Niedrigster Schlusskurs: $8.83 am 2018-12-01
Kursverlauf der Aktie von Millendo Therapeutics, Inc. von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2021 -34.50%
2020 -69.63%
2019 -24.13%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE